Maquet Cardiopulmonary GmbH
$205.7K 14 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
ITF Therapeutics LLC
ITF Therapeutics LLC reported $205,413.93 across General Payments, Research, and Ownership to 296 physicians and teaching hospitals across 307 transactions.
- $205.4K
- All-tracks total
- 307
- Transactions
- 296
- Recipients
- #992
- of 1,925 companies
ITF Therapeutics LLC reported $205,413.93 across all CMS Open Payments tracks (General + Research + Ownership) to 296 physicians and teaching hospitals in Program Year 2024 - ranking #992 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $67,912.99, averaging $693.97 per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer itf-therapeutics-llc ITF Therapeutics LLC
$205.4K · #992/1,925 · 0.0% industry · PY2024
- TOT $205.4K
- RANK #992
- SHARE 0.0%
- TXN 307
- RCP 296
- CAT 4
- GEN $67.9K
- TOP1 10.8%
- PY 2024
Volume peers
Nearest volume peer: Maquet Cardiopulmonary GmbH ($205.7K)
ITF Therapeutics LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for ITF Therapeutics LLC
Rank #992 of 1,925 companies in CMS Open Payments for 2024 belongs to ITF Therapeutics LLC, which reported $205,413.93 across 307 transactions to 296 recipients - a comparatively small 0.0% slice of all industry payments reported nationwide for the year. Averages work out to $669.10 per transaction and $693.97 per recipient.
"Consulting Fee" leads the 4-category general-payment breakdown below at $35.4K (52.2% of General Payments, 20 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
ITF Therapeutics LLC made 4 types of general payments. "Consulting Fee" is the largest category at $35.4K, 52.2% of General Payments.
ITF Therapeutics LLC reports 4 general-payment categories - the top three are Consulting Fee (52.2%), Compensation for Services Other Than Consulting (33.1%), and Food and Beverage (14.1%). The remaining 1 category make up 0.6% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How ITF Therapeutics LLC divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $35.4K | 20 | 52.2% |
| Compensation for Services Other Than Consulting | $22.5K | 10 | 33.1% |
| Food and Beverage | $9.6K | 255 | 14.1% |
| Education | $401.55 | 11 | 0.6% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $26,629.17 (39.2%) of $67,912.99 in this company's General Payments records across 216 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for ITF Therapeutics LLC
The five named recipients with the highest reported General Payments from this company
- 1
Ashutosh Kumar
$7,365.00 across 2 reported transactions
- 2
Erika Finanger
$6,000.00 across 4 reported transactions
- 3
Craig M Mcdonald
$4,800.00 across 2 reported transactions
- 4
Diana P Castro
$4,264.17 across 3 reported transactions
- 5
Aravindhan Veerapandiyan
$4,200.00 across 3 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as ITF Therapeutics LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about ITF Therapeutics LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with ITF Therapeutics LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
Austin Medical Ventures Inc
$204.6K 11 recipients
Compare payment profiles
Polarean, Inc.
$206.6K 40 recipients
Compare payment profiles
OCULUS, Inc.
$204.0K 74 recipients
Compare payment profiles
TruAbutment Inc.
$204.0K 54 recipients
Compare payment profiles
Siesta Medical, Inc.
$203.7K 13 recipients
Compare payment profiles
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.